Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

A new quantitative 3D approach to imaging of structural joint disease.

Turmezei TD, Treece GM, Gee AH, Houlden R, Poole KES.

Sci Rep. 2018 Jun 18;8(1):9280. doi: 10.1038/s41598-018-27486-y.

2.

Evidence for Ongoing Modeling-Based Bone Formation in Human Femoral Head Trabeculae via Forming Minimodeling Structures: A Study in Patients with Fractures and Arthritis.

Sano H, Kondo N, Shimakura T, Fujisawa J, Kijima Y, Kanai T, Poole KES, Yamamoto N, Takahashi HE, Endo N.

Front Endocrinol (Lausanne). 2018 Mar 19;9:88. doi: 10.3389/fendo.2018.00088. eCollection 2018.

3.

How does the femoral cortex depend on bone shape? A methodology for the joint analysis of surface texture and shape.

Gee AH, Treece GM, Poole KES.

Med Image Anal. 2018 Apr;45:55-67. doi: 10.1016/j.media.2018.01.001. Epub 2018 Feb 3.

4.

UK clinical guideline for the prevention and treatment of osteoporosis.

Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N, Hope S, Kanis JA, McCloskey EV, Poole KES, Reid DM, Selby P, Thompson F, Thurston A, Vine N; National Osteoporosis Guideline Group (NOGG).

Arch Osteoporos. 2017 Dec;12(1):43. doi: 10.1007/s11657-017-0324-5. Epub 2017 Apr 19.

5.

An exploratory study into measuring the cortical bone thickness from CT in the presence of metal implants.

Whitmarsh T, Treece GM, Gee AH, Poole KES.

Int J Comput Assist Radiol Surg. 2017 Dec;12(12):2079-2086. doi: 10.1007/s11548-017-1539-z. Epub 2017 Feb 23.

6.

High-Fructose Intake Impairs the Hepatic Hypolipidemic Effects of a High-Fat Fish-Oil Diet in C57BL/6 Mice.

Wooten JS, Nick TN, Seija A, Poole KE, Stout KB.

J Clin Exp Hepatol. 2016 Dec;6(4):265-274. doi: 10.1016/j.jceh.2016.09.001. Epub 2016 Sep 8.

7.

Focal osteoporosis defects play a key role in hip fracture.

Poole KES, Skingle L, Gee AH, Turmezei TD, Johannesdottir F, Blesic K, Rose C, Vindlacheruvu M, Donell S, Vaculik J, Dungl P, Horak M, Stepan JJ, Reeve J, Treece GM.

Bone. 2017 Jan;94:124-134. doi: 10.1016/j.bone.2016.10.020. Epub 2016 Oct 21.

8.

The Effects on the Femoral Cortex of a 24 Month Treatment Compared to an 18 Month Treatment with Teriparatide: A Multi-Trial Retrospective Analysis.

Whitmarsh T, Treece GM, Gee AH, Poole KE.

PLoS One. 2016 Feb 9;11(2):e0147722. doi: 10.1371/journal.pone.0147722. eCollection 2016.

9.

Quantitative 3D analysis of bone in hip osteoarthritis using clinical computed tomography.

Turmezei TD, Treece GM, Gee AH, Fotiadou AF, Poole KE.

Eur Radiol. 2016 Jul;26(7):2047-54. doi: 10.1007/s00330-015-4048-x. Epub 2015 Oct 7.

10.

Mutations in Known Monogenic High Bone Mass Loci Only Explain a Small Proportion of High Bone Mass Cases.

Gregson CL, Wheeler L, Hardcastle SA, Appleton LH, Addison KA, Brugmans M, Clark GR, Ward KA, Paggiosi M, Stone M, Thomas J, Agarwal R, Poole KE, McCloskey E, Fraser WD, Williams E, Bullock AN, Davey Smith G, Brown MA, Tobias JH, Duncan EL.

J Bone Miner Res. 2016 Mar;31(3):640-9. doi: 10.1002/jbmr.2706. Epub 2015 Oct 6.

11.

Response to: Comment on: "Denosumab Rapidly Increases Cortical Bone in Key Locations of the Femur: A 3D Bone Mapping Study in Women With Osteoporosis".

Poole KE, Treece GM, Gee AH, Brown JP, McClung MR, Wang A, Libanati C.

J Bone Miner Res. 2015 Oct;30(10):1939-40. doi: 10.1002/jbmr.2569. Epub 2015 Jul 14. No abstract available.

12.

Association between femur size and a focal defect of the superior femoral neck.

Gee AH, Treece GM, Tonkin CJ, Black DM, Poole KES.

Bone. 2015 Dec;81:60-66. doi: 10.1016/j.bone.2015.06.024. Epub 2015 Jul 2.

13.

Predicting Hip Fracture Type With Cortical Bone Mapping (CBM) in the Osteoporotic Fractures in Men (MrOS) Study.

Treece GM, Gee AH, Tonkin C, Ewing SK, Cawthon PM, Black DM, Poole KE; Osteoporotic Fractures in Men (MrOS) Study.

J Bone Miner Res. 2015 Nov;30(11):2067-77. doi: 10.1002/jbmr.2552. Epub 2015 Jul 14.

14.

The Influence of High-Impact Exercise on Cortical and Trabecular Bone Mineral Content and 3D Distribution Across the Proximal Femur in Older Men: A Randomized Controlled Unilateral Intervention.

Allison SJ, Poole KE, Treece GM, Gee AH, Tonkin C, Rennie WJ, Folland JP, Summers GD, Brooke-Wavell K.

J Bone Miner Res. 2015 Sep;30(9):1709-16. doi: 10.1002/jbmr.2499.

15.

Mapping Bone Changes at the Proximal Femoral Cortex of Postmenopausal Women in Response to Alendronate and Teriparatide Alone, Combined or Sequentially.

Whitmarsh T, Treece GM, Gee AH, Poole KE.

J Bone Miner Res. 2015 Jul;30(7):1309-18. doi: 10.1002/jbmr.2454.

16.

Denosumab rapidly increases cortical bone in key locations of the femur: a 3D bone mapping study in women with osteoporosis.

Poole KE, Treece GM, Gee AH, Brown JP, McClung MR, Wang A, Libanati C.

J Bone Miner Res. 2015 Jan;30(1):46-54. doi: 10.1002/jbmr.2325.

17.

Cortical bone assessed with clinical computed tomography at the proximal femur.

Johannesdottir F, Turmezei T, Poole KE.

J Bone Miner Res. 2014 Apr;29(4):771-83. Review.

18.

A new CT grading system for hip osteoarthritis.

Turmezei TD, Fotiadou A, Lomas DJ, Hopper MA, Poole KE.

Osteoarthritis Cartilage. 2014 Oct;22(10):1360-6. doi: 10.1016/j.joca.2014.03.008. Epub 2014 Mar 15.

19.

Severity mapping of the proximal femur: a new method for assessing hip osteoarthritis with computed tomography.

Turmezei TD, Lomas DJ, Hopper MA, Poole KE.

Osteoarthritis Cartilage. 2014 Oct;22(10):1488-98. doi: 10.1016/j.joca.2014.03.007. Epub 2014 Mar 14.

20.

Elevated circulating Sclerostin concentrations in individuals with high bone mass, with and without LRP5 mutations.

Gregson CL, Poole KE, McCloskey EV, Duncan EL, Rittweger J, Fraser WD, Smith GD, Tobias JH.

J Clin Endocrinol Metab. 2014 Aug;99(8):2897-907. doi: 10.1210/jc.2013-3958. Epub 2014 Feb 25. Erratum in: J Clin Endocrinol Metab. 2015 Aug;100(8):3219. J Clin Endocrinol Metab. 2015 Aug;100(8):3219.

21.

Similarities and differences between sexes in regional loss of cortical and trabecular bone in the mid-femoral neck: the AGES-Reykjavik longitudinal study.

Johannesdottir F, Aspelund T, Reeve J, Poole KE, Sigurdsson S, Harris TB, Gudnason VG, Sigurdsson G.

J Bone Miner Res. 2013 Oct;28(10):2165-76. doi: 10.1002/jbmr.1960.

22.

Cortical thickness mapping to identify focal osteoporosis in patients with hip fracture.

Poole KE, Treece GM, Mayhew PM, Vaculík J, Dungl P, Horák M, Štěpán JJ, Gee AH.

PLoS One. 2012;7(6):e38466. doi: 10.1371/journal.pone.0038466. Epub 2012 Jun 11.

23.

Bisphosphonates in the treatment of osteoporosis.

Poole KE, Compston JE.

BMJ. 2012 May 22;344:e3211. doi: 10.1136/bmj.e3211. No abstract available.

PMID:
22619192
24.

Imaging the femoral cortex: thickness, density and mass from clinical CT.

Treece GM, Poole KE, Gee AH.

Med Image Anal. 2012 Jul;16(5):952-65. doi: 10.1016/j.media.2012.02.008. Epub 2012 Feb 28.

25.

Distribution of cortical bone in the femoral neck and hip fracture: a prospective case-control analysis of 143 incident hip fractures; the AGES-REYKJAVIK Study.

Johannesdottir F, Poole KE, Reeve J, Siggeirsdottir K, Aspelund T, Mogensen B, Jonsson BY, Sigurdsson S, Harris TB, Gudnason VG, Sigurdsson G.

Bone. 2011 Jun 1;48(6):1268-76. doi: 10.1016/j.bone.2011.03.776. Epub 2011 Apr 5.

26.

'Sink or swim': an evaluation of the clinical characteristics of individuals with high bone mass.

Gregson CL, Steel SA, O'Rourke KP, Allan K, Ayuk J, Bhalla A, Clunie G, Crabtree N, Fogelman I, Goodby A, Langman CM, Linton S, Marriott E, McCloskey E, Moss KE, Palferman T, Panthakalam S, Poole KE, Stone MD, Turton J, Wallis D, Warburton S, Wass J, Duncan EL, Brown MA, Davey-Smith G, Tobias JH.

Osteoporos Int. 2012 Feb;23(2):643-54. doi: 10.1007/s00198-011-1603-4. Epub 2011 Apr 1.

27.

Targeted regeneration of bone in the osteoporotic human femur.

Poole KE, Treece GM, Ridgway GR, Mayhew PM, Borggrefe J, Gee AH.

PLoS One. 2011 Jan 14;6(1):e16190. doi: 10.1371/journal.pone.0016190.

28.

Computed tomography of subchondral bone and osteophytes in hip osteoarthritis: the shape of things to come?

Turmezei TD, Poole KE.

Front Endocrinol (Lausanne). 2011 Dec 13;2:97. doi: 10.3389/fendo.2011.00097. eCollection 2011.

29.

Sclerostin and the regulation of bone formation: Effects in hip osteoarthritis and femoral neck fracture.

Power J, Poole KE, van Bezooijen R, Doube M, Caballero-Alías AM, Lowik C, Papapoulos S, Reeve J, Loveridge N.

J Bone Miner Res. 2010 Aug;25(8):1867-76. doi: 10.1002/jbmr.70.

30.

High resolution cortical bone thickness measurement from clinical CT data.

Treece GM, Gee AH, Mayhew PM, Poole KE.

Med Image Anal. 2010 Jun;14(3):276-90. doi: 10.1016/j.media.2010.01.003. Epub 2010 Jan 25.

31.

Changing structure of the femoral neck across the adult female lifespan.

Poole KE, Mayhew PM, Rose CM, Brown JK, Bearcroft PJ, Loveridge N, Reeve J.

J Bone Miner Res. 2010 Mar;25(3):482-91. doi: 10.1359/jbmr.090734.

32.

Femoral neck trabecular bone: loss with aging and role in preventing fracture.

Thomas CD, Mayhew PM, Power J, Poole KE, Loveridge N, Clement JG, Burgoyne CJ, Reeve J.

J Bone Miner Res. 2009 Nov;24(11):1808-18. doi: 10.1359/jbmr.090504.

33.

Bone structure and remodelling in stroke patients: early effects of zoledronate.

Poole KE, Vedi S, Debiram I, Rose C, Power J, Loveridge N, Warburton EA, Reeve J, Compston J.

Bone. 2009 Apr;44(4):629-33. doi: 10.1016/j.bone.2008.11.017. Epub 2008 Dec 11.

34.

Hypovitaminosis D among rheumatology outpatients in clinical practice.

Mouyis M, Ostor AJ, Crisp AJ, Ginawi A, Halsall DJ, Shenker N, Poole KE.

Rheumatology (Oxford). 2008 Sep;47(9):1348-51. doi: 10.1093/rheumatology/ken203. Epub 2008 May 22.

35.

Yearly zoledronic acid in postmenopausal osteoporosis.

Poole KE, Kaptoge S, Reeve J.

N Engl J Med. 2007 Aug 16;357(7):711-2; author reply 714-5. No abstract available.

PMID:
17703530
36.

Hip fractures after stroke and their prevention.

Myint PK, Poole KE, Warburton EA.

QJM. 2007 Sep;100(9):539-45. Epub 2007 Aug 9. Review.

PMID:
17693418
37.

A single infusion of zoledronate prevents bone loss after stroke.

Poole KE, Loveridge N, Rose CM, Warburton EA, Reeve J.

Stroke. 2007 May;38(5):1519-25. Epub 2007 Mar 29.

PMID:
17395868
38.

Osteoporosis and its management.

Poole KE, Compston JE.

BMJ. 2006 Dec 16;333(7581):1251-6. Review. No abstract available.

39.

Reduced vitamin D in acute stroke.

Poole KE, Loveridge N, Barker PJ, Halsall DJ, Rose C, Reeve J, Warburton EA.

Stroke. 2006 Jan;37(1):243-5. Epub 2005 Dec 1.

PMID:
16322500
40.

Risedronate therapy for prevention of hip fracture after stroke in elderly women.

Poole KE, Warburton EA, Reeve J.

Neurology. 2005 Nov 8;65(9):1513-4; author reply 1513-4. No abstract available.

PMID:
16275859
41.

Parathyroid hormone - a bone anabolic and catabolic agent.

Poole KE, Reeve J.

Curr Opin Pharmacol. 2005 Dec;5(6):612-7. Epub 2005 Sep 21. Review.

PMID:
16181808
42.

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation.

Poole KE, van Bezooijen RL, Loveridge N, Hamersma H, Papapoulos SE, Löwik CW, Reeve J.

FASEB J. 2005 Nov;19(13):1842-4. Epub 2005 Aug 25.

PMID:
16123173
43.

Rapid long-term bone loss following stroke in a man with osteoporosis and atherosclerosis.

Poole KE, Warburton EA, Reeve J.

Osteoporos Int. 2005 Mar;16(3):302-5. Epub 2004 Jun 10.

PMID:
15197547
44.

Falls, fractures, and osteoporosis after stroke: time to think about protection?

Poole KE, Reeve J, Warburton EA.

Stroke. 2002 May;33(5):1432-6. Review.

PMID:
11988628

Supplemental Content

Loading ...
Support Center